But even as Ozempic enters India, there is a growing sense globally that Novo may have already lost the obesity drug war to ...

Dr Pooja Reddy promotes three simple diet and lifestyle changes as healthier, more accessible alternative to weight loss ...

Consumer companies are increasingly betting on the male grooming and personal care categories. Wasted digital ad spend in ...

Amy Schumer has erased all her so-called 'fat photos' from Instagram since debuting her new frame - and is now erasing her ...

Kelly Osbourne has not only dropped a lot of pounds, she’s also dropped the f-bomb directed at the people who are criticizing ...

“Caloric restriction, or fasting, is one of the most well-established interventions for extending lifespan and improving ...

There’s trouble brewing beneath the GLP-1 buzz. As Americans embrace blockbuster weight-loss drugs like Ozempic and Wegovy in ...

Novo Nordisk launched Ozempic in India on Friday, pricing the 0.25 mg dose at $24.35 per week and targeting a booming ...

Bills on diagnostic breast cancer testing, GLP-1 medications, lead paint and breastfeeding were signed into law.

Novo Nordisk launches Ozempic in India, outlining prices, doses, and its bid to capture rising diabetes and weight-loss ...

The company also said earlier this week it will drop $6 billion on a new manufacturing facility in Huntsville, Alabama.

A weight loss drug dubbed the "triple G" drug for its effectiveness in mimicking three hunger-regulating hormones showed promising results in new data released Thursday by its maker, Eli Lilly.